20-027-525MG
MilliporeSigma™ Calbiochem™ Berberine Chloride
Manufacturer: MilliporeSigma™
CAS Number: 633-65-8
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 20-027-525MG-Each-of-1 | In Stock | ₹ 4,049.50 |
20-027-525MG - Each of 1
In Stock
Quantity
1
Base Price: ₹ 4,049.50
GST (18%): ₹ 728.91
Total Price: ₹ 4,778.41
Color
Yellow
CAS
633-65-8
Formula Weight
371.81g/mol
Content And Storage
Protect from light
Quantity
25 mg
Description
95% by HPLC (NMR if no UV signal)
Molecular Formula
C20H18NO4+Cl-
Solubility
DMSO or H2O
Form
Powder
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Berberine chloride British Pharmacopoeia (BP) Reference Standard | 633-65-8 | MFCD00011939 | | -- | ₹ 30,963.10 | ||
Berberine Chloride Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 21,538.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Berberine chloride | 633-65-8 | MFCD00011939 | 50mg | -- | ₹ 28,019.87 | ||
Selleck Chemical LLC Berberine chloride 50mg 633-65-8 | -- | ₹ 26,379.60 | ||
Sigma Aldrich Fine Chemicals Biosciences Berberine chloride form | 633-65-8 | MFCD00011939 | 10G | -- | ₹ 13,301.05 | ||
Sigma Aldrich Fine Chemicals Biosciences Berberine chloride form | 633-65-8 | MFCD00011939 | 25G | -- | ₹ 27,801.82 | ||
Sigma Aldrich Fine Chemicals Biosciences Berberine Chloride Form | 633-65-8 | MFCD00011939 | 5g | -- | ₹ 7,271.30 | ||
Berberine chloride | -- | ₹ 60,132.88 | ||
Berberine chloride | -- | ₹ 16,107.60 | ||
Berberine chloride | -- | ₹ 25,893.40 |
Related Products
Description
- A highly potent and selective oxysterol EBI2 (GPR183) agonist (K d ) = 450 pM in a saturation binding assay, and EC 50 = 140 pM over EC 50 = 2.1nM for its enantiomer, 7β,25-OHC, in a GTP-γS binding assay)
- Dose-dependently suppresses forskolin-induced cAMP accumulation in an EBI2-expressing SK-N-MC/CRE-β-galactosidase cell line (IC 50 = 2nM), but not in control cells
- Stimulates migration of LPS-activated spleen B-cells and anti-CD3/CD28-activated CD4 + T-cells in a dose-dependent manner
- In addition, pharmacological inhibition of its biosynthesis in vivo by Clotrimazole, a CYP7B1inhibitor, promotes the migration of adoptively transferred pre-activated B cells to the T/B boundary, mimicking the phenotype of pre-activated B cells in EBI2-deficient mice.